Styromal: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 62707 |
SCHEMBL ID | 16058 |
MeSH ID | M0085404 |
Synonym |
---|
nsc124032 |
nsc-124032 |
nsc137654 |
nsc-137654 |
sma 1440-h resin |
styromal |
sma 2000a |
sma 1420al |
malon ms 20 |
sma 2625a |
sma 1000 |
styrene-maleic anhydride resin |
lytron 820 |
sma 3000a |
styrene maleic anhydride, resin |
styromal 5 |
lytron 810 |
nsc99620 |
sma 17352a |
dylark 230 |
styromal 30 |
povimal st |
lytron 822 |
dylark 231 |
nsc-99620 |
dylark 232 |
sma 4000a |
styrite hs 2 |
arco-sma 1000a |
resin, sma 1440-h |
9011-13-6 |
lpa 39 |
sma 1440h |
sma 1000a |
sma 2000 |
sma 1725a |
sma 3000 |
42912-79-8 |
25736-61-2 |
AKOS015889038 |
WOLATMHLPFJRGC-UHFFFAOYSA-N |
styrene maleic acid anhydride |
maleic anhydride styrene |
styrene maleic anhydride |
styrene/maleic anhydride |
SCHEMBL16058 |
maleic anhydride-styrene |
mfcd00134011 |
DTXSID50911339 |
furan-2,5-dione--ethenylbenzene (1/1) |
109768-17-4 |
furan-2,5-dione;styrene |
Excerpt | Reference | Relevance |
---|---|---|
" Hence, it is concluded that the polymer SMA injected at above doses appears to be safe in our experiment." | ( Preclinical toxicity study of a male injectable antifertility agent (styrene maleic anhydride) in rhesus monkeys, Macaca mulatta. Nath, D; Sethi, N; Singh, RK; Srivastava, RK, 1991) | 0.28 |
" Hence, the polymer is safe at the doses used within 6 months of injection." | ( Long-term toxicity studies of styrene maleic anhydride in rats. Nath, D; Sethi, N; Singh, RK; Srivastava, RK, 1990) | 0.28 |
" The results suggest the polymer SMA to be safe up to 5 times CD in monkeys." | ( Chronic toxicity of styrene maleic anhydride, a male contraceptive, in rhesus monkeys (Macaca mulatta). Bhatia, GS; Sethi, N; Singh, RK; Sinha, N; Srivastava, RK, 1990) | 0.28 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 4 (14.81) | 18.7374 |
1990's | 14 (51.85) | 18.2507 |
2000's | 3 (11.11) | 29.6817 |
2010's | 5 (18.52) | 24.3611 |
2020's | 1 (3.70) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (23.15) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (3.57%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 27 (96.43%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |